Nyt fra tidsskrifterne
Ingen søgeord valgt.
48 emner vises.
BMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background K. pneumoniae become multidrug-resistant (MDR) and commonly poses a serious health threat to patients due to limited therapeutic options. As a result, determining the prevalence and antimicrobial susceptibility patterns of K. pneumoniae isolates from clinical specimens is substantial to patient diagnosis and treatment. Methods and materials A retrospective cross-sectional study was conducted from July 2021 to July 2022 at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. Sociodemographic and laboratory data were collected from registered books using a data collection sheet. All types of samples were collected and processed using standard procedures. Identification of K. pneumoniae was done using Gram stain, colony characterization on culture media, anda series of biochemical tests. Antimicrobial susceptibility testing was done by the Kirby Bauer disc diffusion technique. The data were entered using Epi-info version 7 and exported to SPSS version 20 for analysis. Results Among 2600 clinical specimens, 735 (28.3%) were positive for bacteria, and K. pneumoniae isolates accounted for 147 (20%). Most of them were isolated from neonates and mainly obtained from blood specimens (81.6%). These isolates were 100% resistant to Nalidixic acid, Cefotaxime, and Cefazolin. About 84% and 83.3% of the isolates were also resistant to Ceftriaxone and Tetracycline, respectively. However, they are sensitive to Nitrofurantoin (86.6%), Imipenem (85.7%), Meropenem (79%), and Amikacin (78.3%). The overall proportion of MDR K. pneumoniae isolates accounted for 57.1%. Conclusion The magnitude of MDR K. pneumoniae was very alarming. Therefore, strengthening antimicrobial stewardship programs and antimicrobial surveillance practices is strongly recommended in the study area.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Transfusion-related acute lung injury (TRALI) is a rare life-threatening complication of blood product transfusion. Intravenous immunoglobulin (IVIG)-related TRALI is scarcely reported. Case presentation A 63-year-old male patient suffering from multiple sclerosis treated with half-yearly rituximab infusions, was hospitalized due to dry cough, daily fever and shivering for seven days despite antibiotic therapy. Because of the history of COVID-19 one month prior without the symptoms having improved since, persistent bilateral multifocal areas of ground glass opacities in chest computed tomography and positive SARS-CoV-2 PCR from bronchoalveolar lavage with a cycling time of 30.1 COVID-19 due to long-shedding SARS-CoV-2 under immunosuppression with rituximab was diagnosed. He received treatment with nirmatrelvir und ritonavir and because of diagnosed IgG deficiency additionally a single dose of 20 g IVIG. During the IVIG infusion, the patient acutely developed tachycardia, hypotension, fever, chills, and hypoxemic respiratory failure due to pulmonary edema. TRALI was promptly diagnosed, and the patient was transferred to the intensive care unit for non-invasive ventilation for less than 24 h. The patient was discharged home from regular ward 72 h later in a good general condition and no remaining symptoms of TRALI. Conclusion IVIG-related TRALI is a rare but life-threating condition and prompt recognition is lifesaving. Due to an increased use of IVIG not only in long-shedding SARS-CoV-2, an increase of TRALI incidence is expected.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background On March 16th 2024, the first case of Human infection with avian influenza H10N3 since the end of the global COVID-19 Pandemic was reported in Kunming, China. To enhance comprehension of the source of infection and risk factors of the H10N3 virus infection, this case report summarizes the clinical features, epidemiological investigation, and laboratory test results. Provides recommendations for the prevention and control of Human infection with avian influenza H10N3. Case presentation A 51-year-old male with a history of COVID-19 infection and a smoking habit of 30 years, worked in livestock breeding and was exposed to sick and dead poultry before falling ill with fever and chills on 28th February 2024. A week later, he was diagnosed with severe pneumonia, influenza, and respiratory failure by the Third People\'s Hospital of Kunming(KM-TPH). He was discharged on 17th April and none of his 6 close contacts showed any symptoms of illness. Environmental samples taken from the epidemic spot revealed that peacock feces tested positive for avian influenza sub-type H9 and waterfowl specimens showed positive results for avian influenza sub-type H5. Gene sequencing conducted on positive specimens from the patient\'s respiratory tract by the Chinese Centre for Disease Control and Prevention (CCDC) showed a high degree of similarity (98.6–99.5%) with the strain responsible for the second global case of human infected with H10N3 (reported from Zhejiang, China 2022). Conclusions According to the available epidemiological information, there is limited evidence to suggest that H10N3 viruses are excessively lethal. However, adaptive site mutations have been observed in the H10N3 isoform of mammals. While it is unlikely that the H10N3 virus will spread among humans, the possibility of additional cases cannot be entirely ruled out. Symptoms of human infection with H10N3 avian influenza are similar to those of common respiratory infections, which may result in them being overlooked during initial clinical consultations. Therefore, it is essential to improve surveillance of the H10 sub-type of avian influenza and to increase the awareness of hospital-related workers of cases of pneumonia of unknown origin.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background This study aimed to investigate the differential expression levels of the cGAS-STING pathway in peripheral blood mononuclear cells (PBMCs) of spinal tuberculosis (TB) patients with different progression and its feasibility as a diagnostic marker. Methods Peripheral blood and medical records of 25 patients with spinal TB and 10 healthy individuals, were prospectively collected and analyzed. PBMCs and serum were extracted from peripheral blood and the expression levels of the cGAS-STING pathway in PBMCs were measured by real-time PCR (RT-PCR) and serum interferon β (IFN-β) expression levels were measured by enzyme-linked immunosorbent assay (ELISA). The expression of Interferon regulatory Factor 3 (IRF3) in PBMCs was measured using western blot. Statistical analysis was performed using the SPSS 26.0 statistical package. Results The results showed that the expression level of the TANK-binding kinase 1 (TBK1) and IRF3 was significantly higher in PBMCs (P
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Although a universal vaccine is available and Ethiopia is working outstandingly towards measles elimination, a recurrent measles outbreak has occurred each year in different parts of the country. Therefore, understanding the epidemiology of measles cases, the incidence of confirmed measles virus cases and related risk factors is crucial. Here, we conducted a systematic review and meta-analysis to summarize information regarding the epidemiology, measles incidence rate and risk factors for national measles infections occurring in the past two decades, from 2000 to 2023. Methods Data from electronic databases, including PubMed, African Journal Online, WHO databases and Google Scholars, were searched to identify studies describing measles outbreaks, incidence rates and associated factors in Ethiopia that occurred between 2000 and 2023. Important basic information was extracted in an Excel spreadsheet and imported into Comprehensive Meta-analysis Software version 3 to evaluate the associations between measles outbreaks and different risk factors. We pooled the odds ratios (ORs) and 95% confidence intervals (CIs) for every included risk factor to evaluate the associations with measles outbreaks. Results We included 36 studies involving 132,502 patients with confirmed measles cases in Ethiopia. The results of this systematic review and meta-analysis revealed that measles outbreaks were more frequently reported in the Oromia region (73,310 (33.1%)), followed by the Southern Nation Nationalities of Ethiopia region (29,057 (13.4%)). The overall pooled analysis indicated that the prevalence of measles susceptibility was 67.5% (95% CI: 67.3–67.8%), with an I2 of 99.86% and a p value for heterogeneity
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background During the pandemic period, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutated, leading to changes in the disease’s severity and the therapeutic effect of drugs accordingly. This study aimed to present the actual use of therapeutics and clinical outcomes based on the prevalence of each variant using real-world data. Methods We analyzed the electronic medical records of adult patients admitted to Busan Medical Center after confirming coronavirus disease 2019 (COVID-19) from February 1, 2020, to June 30, 2022. Patients with mild-to-moderate COVID-19 who were at a high risk of disease progression were selected as study subjects, and the time period was classified according to the variants as ancestral strain, Delta variant, or Omicron variant. We compared drug use status and clinical outcomes by time period. Results Among all 3,091 patients, corticosteroids were the most commonly used therapy (56.0%), being used most frequently in the Delta variant (93.0%), followed by the Omicron variant (42.9%) and ancestral strain (21.2%). Regdanvimab accounted for the majority of therapeutic use in the Delta variant (82.9%) and ancestral strain (76.8%), whereas remdesivir was most frequently used during the Omicron variant period (68.9%). The composite outcomes of death or disease aggravation were ranked in the order of the Delta variant, Omicron variant, and ancestral strain (14.5, 11.9, and 6.0%, respectively, P
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Microcirculation abnormality in septic shock is closely associated with organ dysfunction and mortality rate. It was hypothesized that the arterial blood glucose and interstitial fluid (ISF) glucose difference (GA−I) as a marker for assessing the microcirculation status can effectively evaluate the severity of microcirculation disturbance in patients with septic shock. Methods The present observational study enrolled patients with septic shock admitted to and treated in the intensive care unit (ICU) of a tertiary teaching hospital. The parameters reflecting organ and tissue perfusion, including lactic acid (Lac), skin mottling score, capillary refill time (CRT), venous-to-arterial carbon dioxide difference (Pv-aCO2), urine volume, central venous oxygen saturation (ScvO2) and GA−I of each enrolled patient were recorded at the time of enrollment (H0), H2, H4, H6, and H8. With ICU mortality as the primary outcome measure, the ICU mortality rate at any GA−I interval was analyzed. Results A total of 43 septic shock patients were included, with median sequential organ failure assessment (SOFA) scores of 10.5 (6–16), and median Acute Physiology and Chronic Health Evaluation (APACHAE) II scores of 25.7 (9–40), of whom 18 died during ICU stay. The GA−I levels were negative correlation with CRT (r = 0.369, P
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background The 2016 IDSA guideline recommends a treatment duration of at least 7 days for hospital-acquired (HAP)/ventilator-associated pneumonia (VAP). The limited literature has demonstrated higher rates of recurrence for non-glucose fermenting gram-negative bacilli with short course therapy, raising the concern of optimal treatment duration for these pathogens. Therefore, we aimed to compare the outcomes for patients receiving shorter therapy treatment (≤ 8 days) versus longer regimen (> 8 days) for the treatment of multidrug resistant (MDR) Pseudomonas pneumonia. Methods A single-center, retrospective cohort study was conducted to evaluate adult patients receiving an antimicrobial regimen with activity against MDR Pseudomonas aeruginosa in respiratory culture between 2017 and 2020 for a minimum of 6 consecutive days. Exclusion criteria were inmates, those with polymicrobial pneumonia, community-acquired pneumonia, and infections requiring prolonged antibiotic therapy. Results Of 427 patients with MDR P. aeruginosa respiratory isolates, 85 patients were included. Baseline characteristics were similar among groups with a median age of 65.5 years and median APACHE 2 score of 20. Roughly 75% had ventilator-associated pneumonia. Compared to those who received ≤ 8 days of therapy, no difference was seen for clinical success in patients treated for more than 8 days (80% vs. 65.5%, p = 0.16). The number of 30-day and 90-day in-hospital mortality, 30-days relapse, and other secondary outcomes did not significantly differ among the treatment groups. Conclusions Prolonging treatment duration beyond 8 days did not improve patient outcomes for MDR P. aeruginosa HAP/VAP.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Aortic valve infective endocarditis (IE) is associated with significant morbidity and mortality. We aimed to describe the clinical profile, risk factors and predictors of short- and long-term mortality in patients with aortic valve IE treated with aortic valve replacement (AVR) compared with a control group undergoing AVR for non-infectious valvular heart disease. Methods Between January 2008 and December 2013, a total of 170 cases with IE treated with AVR (exposed cohort) and 677 randomly selected non-infectious AVR-treated patients with degenerative aortic valve disease (controls) were recruited from three tertiary hospitals with cardiothoracic facilities across Scandinavia. Crude and adjusted hazard ratios (HR) were estimated using Cox regression models. Results The mean age of the IE cohort was 58.5 ± 15.1 years (80.0% men). During a mean follow-up of 7.8 years (IQR 5.1-10.8 years), 373 (44.0%) deaths occurred: 81 (47.6%) in the IE group and 292 (43.1%) among controls. Independent risk factors associated with IE were male gender, previous heart surgery, underweight, positive hepatitis C serology, renal failure, previous wound infection and dental treatment (all p
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Risk scores facilitate the assessment of mortality risk in patients with community-acquired pneumonia (CAP). Despite their utilities, there is a scarcity of evidence comparing the various RS simultaneously. This study aims to evaluate and compare multiple risk scores reported in the literature for predicting 30-day mortality in adult patients with CAP. Methods A retrospective cohort study on patients diagnosed with CAP was conducted across two hospitals in Colombia. The areas under receiver operating characteristic curves (ROC-curves) were calculated for the outcome of survival or death at 30 days using the scores obtained for each of the analyzed questionnaires. Results A total of 7454 potentially eligible patients were included, with 4350 in the final analysis, of whom 15.2% (662/4350) died within 30 days. The average age was 65.4 years (SD: 21.31), and 59.5% (2563/4350) were male. Chronic kidney disease was 3.7% (9.2% vs. 5.5%; p
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Managing infectious complications after kidney transplantation (KT) remains a major challenge. Infections are the leading non-cardiovascular cause of death among kidney transplant recipients (KTr). The urinary tract is particularly vulnerable to infections in this group, leading to high levels of morbidity and mortality, as well as significant economic costs. Case presentation This case report presents the first documented instance of extensive thigh pyomyositis resulting from cystic fistulae in an 84-year-old KTr. The patient was referred to our hospital with acute onset fever, pain in the inner thighs and pyuria. A CT scan revealed bilateral pyomyositis of the thighs, characterized by multiple abscesses in the adductor muscles and hydroaerobic levels. Additionally, cystic fistulae complicated by pubic symphysis osteitis were identified. Conclusion In KTr, lower limb pyomyositis resulting from a urinary tract infection is an extremely rare and significantly worsens the overall prognosis for these patients.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and mechanisms in MRSA isolates, especially after the first dalbavancin-resistant MRSA strain in our hospital in 2016. Methods This study investigated 55 MRSA bloodstream isolates (02/2015–02/2021) from the University Hospital of the Medical University of Vienna, Austria. The MICs of dalbavancin, linezolid, and daptomycin were assessed. Two isolates (16–33 and 19–362) resistant to dalbavancin were analyzed via whole-genome sequencing, with morphology evaluated using transmission electron microscopy (TEM). Results S.aureus BSI strain 19–362 had two novel missense mutations (p.I515M and p.A606D) in the pbp2 gene. Isolate 16–33 had a 534 bp deletion in the DHH domain of GdpP and a SNV in pbp2 (p.G146R). Both strains had mutations in the rpoB gene, but at different positions. TEM revealed significantly thicker cell walls in 16–33 (p
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Healthcare professionals (HCPs) play a significant role in the decision-making process of pregnant women on maternal vaccinations. Whereas a high proportion of HCPs discuss maternal vaccinations with pregnant women, confidence in discussing maternal vaccinations is lacking and HCPs experience inadequate training to discuss maternal vaccinations with pregnant women. Furthermore, different practical barriers might influence the consultation process, such as lack of time. More studies on the barriers, as well as facilitators, to discussing maternal vaccinations is needed and will help us to better understand and support HCPs in discussing maternal vaccinations. Methods This qualitative study involved semi-structured interviews with fourteen HCPs working as midwives or gynaecologists in the Netherlands. An integrated theoretical approach was used to inform data collection and analysis. Thematic analysis was conducted using inductive and deductive approaches. This study followed the COnsolidated criteria for REporting Qualitative research (COREQ) guidelines. Results The thematic analysis of the data pointed to the following five themes of HCP counselling: the consultation process, attitude, perceived norm, perceived control and improvement ideas. Most HCPs follow a similar approach in maternal pertussis vaccination consultations, beginning by assessing clients’ understanding, providing basic information, and addressing questions. However, consultation timing and prioritization vary among HCPs. Challenges in consultations include client requests for clear advice, with HCPs trained to remain neutral, emphasizing client autonomy in decision-making. Most HCPs acknowledge the importance of their consultations in informing pregnant women about maternal pertussis vaccination. Conclusions This study offers a confirmation of the awareness of the pivotal role of HCPs in informing pregnant women about the maternal pertussis vaccination. HCPs stress the importance of neutral counselling, enabling pregnant women to make well-informed decisions independently. Because of upcoming vaccine hesitancy nowadays, HCPs must be equipped with the knowledge and confidence to navigate difficult conversations. Continuous education and training might help to increase HCPs’ confidence in handling difficult consultations. Additionally, making the information materials for pregnant women available in multiple languages and incorporating more visuals to enhance comprehension could support HCPs in reaching a broader group of pregnant women.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Pneumonia stands as a significant global contributor to mortality, particularly in South Africa, where it ranks as the second leading cause of death. The country’s high prevalence of HIV infection compounds this issue, significantly increasing mortality rates associated with community-acquired pneumonia (CAP). Objective This study aimed to audit CAP patient management at a regional rural hospital in KwaZulu-Natal. Method A retrospective review of patient files from September to December 2016 was undertaken. Data extraction from clinical files, conducted according to inclusion criteria, was transferred to a data collection sheet and analyzed using SPSS version 21. Results The review encompassed 124 patient files over four months, revealing that 117 (94.4%) patients were not managed by the Standard Treatment Guidelines and Essential Medicines List for South Africa. Of the patients admitted with CAP, 54% were HIV positive, and 49 (39.5%) patients succumbed to the illness. Notably, none of the patients underwent assessment using a severity score. Conclusion The findings underscore a need for more adherence to South African guidelines for managing CAP among staff at the rural regional hospital. This leads to severe consequences, exemplified by the high mortality rate. Urgent intervention is required to incorporate severity assessment scores into pneumonia evaluations, thus enabling appropriate clinical management. Contribution This study sheds light on the significant impact of CAP within the South African hospital context, delineating critical gaps in clinical care and emphasizing the imperative to address clinical inertia.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background To mitigate hospital-acquired transmission of coronavirus disease 2019 (COVID-19), various prevention and control measures have been strictly implemented in medical institutions. These stringent measures can potentially reduce the incidence of hospital-acquired respiratory infections. This study aimed to assess if there were changes in the prevalence of hospital-acquired respiratory infections during a period of national attention focused on COVID-19 prevention. Methods A retrospective analysis of the clinical data from adult patients with hospital-acquired respiratory infections admitted between October and December 2019 and during the same period in 2020 was performed. All patients were referred from a general hospital in Beijing China and COVID-19 patients were not treated at the hospital. Hospital-acquired respiratory infections were diagnosed based on the criteria of the Centers for Disease Control and Prevention/National Healthcare Safety Network (CDC/NHSN). A comparison of the incidence and mortality rate of hospital-acquired respiratory infections between the two selected time periods was conducted. Additionally, multivariate logistics regression analysis was used to identify mortality-associated risk factors. Results This study included 2,211 patients from October to December 2019 (pre-COVID-19 pandemic) and 2,921 patients from October to December 2020 (during the COVID-19 pandemic). The incidence of hospital-acquired respiratory infections in 2019 and 2020 was 4.7% and 2.9%, respectively, with odds ratio (OR): 0.61, 95% confidence interval (CI): 0.46–0.81, and P = 0.001. In-hospital mortality of hospital-acquired respiratory infections in 2019 and 2020 was 30.5% and 38.4%, respectively, with OR: 1.42, 95%CI: 0.78–2.59, and P = 0.25. Multivariate logistics regression analysis revealed that a history of previous malignancy (OR: 2.50, 95%CI: 1.16–5.35, P = 0.02), was associated with in-hospital mortality. Conclusions The incidence of hospital-acquired respiratory infections was significantly decreased following the implementation of various prevention and control measures during the COVID-19 pandemic. A history of previous malignancy was associated with higher in-hospital mortality in older inpatients with hospital-acquired respiratory infections.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Universal antiretroviral treatment (ART) for pregnant women has reduced mother-to-child transmission risk significantly. However, not all women on ART are virally suppressed during pregnancy and lactation. In addition to poor adherence to ART, co-infections particularly other sexually transmitted infections (STIs) are known to increase the risk of HIV acquisition and HIV transmission. While the prevalence of STIs during pregnancy has been well studied, the prevalence of STIs in the postpartum period and its association with HIV viral suppression are underreported. Methods In this cross-sectional study, we determined the prevalence of STIs among adolescent girls and young women (AGYW) living with HIV (WLHIV) and without HIV (WNLHIV) at their 6–14 week postnatal clinic visit in a high HIV prevalence district in South Africa. All women were examined for STI-related symptoms and had vaginal swabs collected and stored for later STI testing. Vaginal swabs were tested for Trichomonas vaginalis (T.vaginalis), Chlamydia trachomatis (C. trachomatis), Neisseria gonorrhoeae (N. gonorrhoea) and herpes simplex virus-2 (HSV-2) using PCR. All women were tested for bacterial vaginosis (BV) using the Nugent scoring criteria. WLHIV had a blood sample collected for HIV viral load, Hepatitis B and syphilis. Results Included in this analysis were 82 WLHIV and 102 WNLHIV. Between 6 and 14 weeks postpartum, 40 (21.7%) AGYW tested positive for any STI and among these 15 (37.5%) were symptomatic and received empirical treatment. C. trachomatis was most commonly detected (10.9%), followed by HSV-2 (7.7%), T. vaginalis (3.8%) and N. gonorrhoea (1.6%). WLHIV were more likely to test positive for an STI (OR 2.0; 0.96–3.96) and BV (OR 4.2; 95%CI 2.1–8.1) compared to WNLHIV. Among WLHIV on ART, 70.5% had an undetectable plasma viral load (PVL) and 20.5% had a PVL > 1000 copies/ml. Testing positive for any STI or BV at the postpartum visit was not associated with PVL > 1000 copies/ml (OR 1.33; 95%CI 0.38–4.64). Conclusion We report a high prevalence of largely asymptomatic STIs and BV in the early postpartum period and STIs in WLHIV were not associated with unsuppressed PVL.The high STI positivity rate among WNLHIV has implications for HIV risk during the postpartum period, and subsequently breastfeeding transmission.
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Most Chinese blood centers have implemented mini pool (MP) HBV nucleic acid testing (NAT) together with HBsAg ELISA in routine blood donor screening for HBV infection since 2015, and a few centers upgraded MP to individual donation (ID) NAT screening recently, raising urgent need for cost-benefit analysis of different screening strategies. In an effort to prevent transfusion-transmitted infections (TTIs) for HBV, cost-benefit analyses of three different screening strategies: HBsAg alone, HBsAg plus MP NAT and HBsAg plus ID NAT were performed in blood donors from southern China where HBV infection was endemic. Methods MP-6 HBV NAT and ID NAT were adopted in parallel to screen blood donors for further comparative analysis. On the basis of screening data and the documented parameters, the number of window period (WP) infection, HBV acute infection, chronic hepatitis B infection (CHB) and occult hepatitis B infection (OBI) was evaluated, and the potential prevented HBV TTIs and benefits of these three strategies were predicted based on cost-benefit analysis by an estimation model. Results Of 132,323 donations, the yield rate for HBsAg-/DNA + screened by ID NAT (0.12%) was significantly higher than that by MP NAT (0.058%, P
Læs mere Tjek på PubMedBMC Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
Abstract Background Sepsis-associated encephalopathy (SAE) patients often experience changes in intracranial pressure and impaired cerebral autoregulation. Mean arterial pressure (MAP) plays a crucial role in cerebral perfusion pressure, but its relationship with mortality in SAE patients remains unclear. This study aims to investigate the relationship between MAP and the risk of 28-day and in-hospital mortality in SAE patients, providing clinicians with the optimal MAP target. Methods We retrospectively collected clinical data of patients diagnosed with SAE on the first day of ICU admission from the MIMIC-IV (v2.2) database. Patients were divided into four groups based on MAP quartiles. Kruskal-Wallis H test and Chi-square test were used to compare clinical characteristics among the groups. Restricted cubic spline and segmented Cox regression models, both unadjusted and adjusted for multiple variables, were employed to elucidate the relationship between MAP and the risk of 28-day and in-hospital mortality in SAE patients and to identify the optimal MAP. Subgroup analyses were conducted to assess the stability of the results. Results A total of 3,816 SAE patients were included. The Q1 group had higher rates of acute kidney injury and vasoactive drug use on the first day of ICU admission compared to other groups (P
Læs mere Tjek på PubMedHarshini WeerasingheHelen StöltingAdam J. RoseAna Traven1Department of Biochemistry and Molecular Biology and the Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia2Centre to Impact AMR, Monash University, Clayton, Victoria, Australia3Department of Biochemistry and Molecular Biology and the Metabolism, Diabetes and Obesity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, AustraliaJoseph Heitman
Microbiology and Molecular Biology Reviews, 5.09.2024
Tilføjet 5.09.2024
Qianyu Hu, Liang Huang, Yaoyu Yang, Ye Xiang, Jintao Liu
Science Advances, 5.09.2024
Tilføjet 5.09.2024
Alexander P. Ligocki, Augustine V. Vinson, Anthony T. Yachnis, William A. Dunn, Douglas E. Smith, Elizabeth A. Scott, Jimena V. Alvarez-Castanon, Daniel E. Baez Montalvo, Olivia G. Frisone, Gary A. J. Brown, Joel E. Pessa, Edward W. Scott
Science Advances, 5.09.2024
Tilføjet 5.09.2024
Vera Buerger, Sandra Hadl, Martina Schneider, Michaela Schaden, Romana Hochreiter, Annegret Bitzer, Karin Kosulin, Robert Mader, Oliver Zoihsl, Andrea Pfeiffer, Ana Paula Loch, Eolo Morandi, Mauricio Lacerda Nogueira, Carlos Alexandre Antunes de Brito, Julio Croda, Mauro Martins Teixeira, Ivo Castelo-Branco Coelho, Ricardo Gurgel, Allex Jardim da Fonseca, Marcus Vinícius Guimarães de Lacerda, Edson Duarte Moreira, Ana Paula Rocha Veiga, Katrin Dubischar, Nina Wressnigg, Susanne Eder-Lingelbach, Juan Carlos Jaramillo
Lancet Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
VLA1553 was generally safe and induced seroprotective titres in almost all vaccinated adolescents with favourable safety data in adolescents who were seropositive at baseline. The data support the use of VLA1553 for the prevention of disease caused by the chikungunya virus among adolescents and in endemic areas.
Læs mere Tjek på PubMedSuzanne M E Kuijpers, David T P Buis, Kirsten A Ziesemer, Reinier M van Hest, Rogier P Schade, Kim C E Sigaloff, Jan M Prins
Lancet Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
The available evidence for non-ICU CAP and AECOPD supports a short-course treatment duration of 5 days in patients who have clinically improved. Efforts of the scientific community should be directed at implementing this evidence in daily practice. High-quality RCTs are needed to underpin even shorter treatment durations for CAP and AECOPD, to establish the optimal treatment duration of HAP and acute sinusitis, and to evaluate shorter duration using an optimal penicillin dosing schedule in patients with pharyngotonsillitis.
Læs mere Tjek på PubMedDaniele Ghezzi, Gianmarco Mangiaterra, Arianna Scardino, Mauro Fehervari, Mauro Magnani, Barbara Citterio, Emanuela Frangipani
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Daniele Ghezzi, Gianmarco Mangiaterra, Arianna Scardino, Mauro Fehervari, Mauro Magnani, Barbara Citterio, Emanuela Frangipani Microbiologically Influenced Corrosion (MIC) is one of the main threats for marine infrastructures, leading to severe safety and environmental risks associated with structural failures and/or leakages of dangerous fluids, together with potential huge economic losses and reputational damage for the involved parts. For a safe design and a proper installation of infrastructure systems in contact with the seabed, a deep knowledge of the site-specific microbial community of the sediments should be beneficial. Therefore, in addition to the simple detection or the sole quantification of Sulphate-Reducing Bacteria (SRB), the whole characterization of the microbial members involved in MIC phenomena is desirable. In this study, 16S rRNA-based comparison between bacterial communities thriving in offshore and nearshore marine sediments was performed, with a focus on the main bacterial groups putatively responsible for MIC. The nearshore sediments were significantly enriched in bacterial members associated with human and organic compounds contamination belonging to the Bacteroidota, Desulfobacterota, and Firmicutes phyla, while the offshore sediments hosted Alphaproteobacteria, Nitrospinota, and Nitrospirota members, representative of a low anthropogenic impact. Quantitative PCR targeting the dsrA gene and detailed community analyses revealed that the nearshore sediments were significantly enriched in SRB mainly affiliated to the Desulfobulbus and Desulfosarcina genera potentially involved in biocorrosion, compared to the offshore ones. These results suggest that the bacterial community associated with the high concentration of organic compounds derived by an elevated anthropogenic impact is likely to favour MIC. Such observations highlight the importance of microbiological investigations as prevention strategy against MIC processes, aiming both at characterizing sites for the establishment of new infrastructures and at monitoring those already installed.
Læs mere Tjek på PubMedMoses Mukosha, Abigail Hatcher, Mwansa Ketty Lubeya, Innocent Maposa, Benjamin H. Chi, Wilbroad Mutale
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Moses Mukosha, Abigail Hatcher, Mwansa Ketty Lubeya, Innocent Maposa, Benjamin H. Chi, Wilbroad Mutale Background Persistent hypertension is common after preeclampsia and is causally tied to later cardiovascular risks. This study examined whether being HIV-infected and on antiretroviral therapy (ART) is associated with persistent postpartum hypertension among women diagnosed with preeclampsia. Methods We conducted a six-month prospective cohort study at Kanyama and Women and Newborn hospitals from January 01, 2022, to June 30, 2023, among 190 women diagnosed with preeclampsia (59 HIV-positive, 131 HIV-negative). Sociodemographic and clinical characteristics were collected at delivery, six weeks, three months and six months after giving birth. Persistent hypertension was diagnosed if a participant presented with elevated blood pressure ≥140mmHg and/or diastolic blood pressure ≥90mmHg and/or taking medication for hypertension at the study visit. We used a generalized estimating equation to describe the relationship between treated HIV and persistent hypertension six months following delivery. Results We retained 136 participants (71.6%) to six months postpartum, at a median age of 30 years. Overall, persistent hypertension at six weeks, three months, and six months postpartum was common (37.4%, 17.1% and 16.9%, respectively). Six-week postpartum prevalence was higher in the HIV group than HIV-negative group (54.6% vs 28.8%, p
Læs mere Tjek på PubMedYoungchul Song, Byungun Yoon
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Youngchul Song, Byungun Yoon As the influence and risk of infectious diseases increase, efforts are being made to predict the number of confirmed infectious disease patients, but research involving the qualitative opinions of social media users is scarce. However, social data can change the psychology and behaviors of crowds through information dissemination, which can affect the spread of infectious diseases. Existing studies have used the number of confirmed cases and spatial data to predict the number of confirmed cases of infectious diseases. However, studies using opinions from social data that affect changes in human behavior in relation to the spread of infectious diseases are inadequate. Therefore, herein, we propose a new approach for sentiment analysis of social data by using opinion mining and to predict the number of confirmed cases of infectious diseases by using machine learning techniques. To build a sentiment dictionary specialized for predicting infectious diseases, we used Word2Vec to expand the existing sentiment dictionary and calculate the daily sentiment polarity by dividing it into positive and negative polarities from collected social data. Thereafter, we developed an algorithm to predict the number of confirmed infectious patients by using both positive and negative polarities with DNN, LSTM and GRU. The method proposed herein showed that the prediction results of the number of confirmed cases obtained using opinion mining were 1.12% and 3% better than those obtained without using opinion mining in LSTM and GRU model, and it is expected that social data will be used from a qualitative perspective for predicting the number of confirmed cases of infectious diseases.
Læs mere Tjek på PubMedJean M. Mondo, Géant B. Chuma, Henri M. Matiti, Jacques B. Kihye, Espoir M. Bagula, Katcho Karume, Charles Kahindo, Anthony Egeru, Jackson-Gilbert M. Majaliwa, Paterne A. Agre, Patrick A. Adebola, Asrat Asfaw
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Jean M. Mondo, Géant B. Chuma, Henri M. Matiti, Jacques B. Kihye, Espoir M. Bagula, Katcho Karume, Charles Kahindo, Anthony Egeru, Jackson-Gilbert M. Majaliwa, Paterne A. Agre, Patrick A. Adebola, Asrat Asfaw The traditional crop calendar for yam (Dioscorea spp.) in South-Kivu, eastern Democratic Republic of Congo (DRC), is becoming increasingly inadequate given the significant climatic variability observed over the last three decades. This study aimed at: (i) assessing trends in weather data across time and space to ascertain climate change, and (ii) optimizing the yam crop calendar for various South-Kivu agro-ecological zones (AEZs) to adapt to the changing climate. The 1990–2022 weather data series were downloaded from the NASA-MERRA platform, bias correction was carried out using local weather stations’ records, and analyses were performed using RClimDex 1.9. Local knowledge and CROPWAT 8.0 were used to define planting dates for yam in different AEZs. Results showed the existence of four AEZs in the South-Kivu province, with contrasting altitudes, temperatures, and rainfall patterns. Climate change is real in all these South-Kivu’s AEZs, resulting either in rainfall deficits in some areas, or extreme rainfall events in others, with significant temperature increases across all AEZs. Suitable yam planting dates varied with AEZs, September 15th and 20th were recommended for the AEZ 2 while October 15th was optimal for AEZ 1, AEZ 3, and AEZ 4. However, none of the planting date scenarios could meet the yam water requirements in AEZ1, AEZ3, and AEZ4, since the effective rainfall (Pmm) was always inferior to the plant water demand (ETc), meaning that soil water conservation practices are needed for optimum plant growth and yield in these AEZs. This study does not recommend planting yam during the short rainy season owing to prolonged droughts coinciding with critical growth phases of yam, unless supplemental irrigation is envisaged. This study provided insights on the nature of climate change across the past three decades and suggested a yam crop calendar that suits the changing climate of eastern DRC.
Læs mere Tjek på PubMedShayan Majidifar, Arash Zabihian, Mohsen Hooshmand
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Shayan Majidifar, Arash Zabihian, Mohsen Hooshmand Combining different drugs synergistically is an essential aspect of developing effective treatments. Although there is a plethora of research on computational prediction for new combination therapies, there is limited to no research on combination therapies in the treatment of viral diseases. This paper proposes AI-based models for predicting novel antiviral combinations to treat virus diseases synergistically. To do this, we assembled a comprehensive dataset comprising information on viral strains, drug compounds, and their known interactions. As far as we know, this is the first dataset and learning model on combination therapy for viruses. Our proposal includes using a random forest model, an SVM model, and a deep model to train viral combination therapy. The machine learning models showed the highest performance, and the predicted values were validated by a t-test, indicating the effectiveness of the proposed methods. One of the predicted combinations of acyclovir and ribavirin has been experimentally confirmed to have a synergistic antiviral effect against herpes simplex type-1 virus, as described in the literature.
Læs mere Tjek på PubMedSyarif Rohimi, Bambang Budi Siswanto, Muchtaruddin Mansyur, Djajadiman Gatot, Ina Sutanto, Jacub Pandelaki, Amiliana M. Soesanto, Teddy Ontoseno
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Syarif Rohimi, Bambang Budi Siswanto, Muchtaruddin Mansyur, Djajadiman Gatot, Ina Sutanto, Jacub Pandelaki, Amiliana M. Soesanto, Teddy Ontoseno Magnetic resonance imaging T2* screening is the gold standard for detecting cardiac iron overload in thalassemia, but its implementation in Indonesia is limited by the high costs. A predicting formula and scoring system based on low-cost investigations is needed. This cross-sectional study was conducted among thalassemia aged 6–18 years at Rumah Sakit Anak dan Bunda RSAB Harapan Kita Indonesia, during October 2017 to April 2019. All subjects were scheduled for clinical examination, laboratory tests, ECGs, echocardiography, tissue Doppler imaging, and MRIT2*. Multivariate logistic regression was used to identify the formula, simplifying to a scoring system, and risk classification for myocardial iron overload using odds ratio (OR) and 95% confidence interval (CI). Significance was set as p
Læs mere Tjek på PubMedQian Wang, You Zhou, Gang Wang, Xinyu Pan, Sha Sha, Zhe Wang, Yinqi Liu, Tengfei Tian, Sixiang Liang
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Qian Wang, You Zhou, Gang Wang, Xinyu Pan, Sha Sha, Zhe Wang, Yinqi Liu, Tengfei Tian, Sixiang Liang Background In context of COVID-19 as a collective trauma and the intense involvement of healthcare workers (HCWs) in the pandemic, perceived stress continues to have a tremendous impact on their psychological well-being. However, few studies have attempted to delineate the underlying mechanisms. This study examined whether COVID-19-related traumatic stress symptoms and mentalization act as mediators. Methods A sample of HCWs (N = 2610) from 22 hospitals in Beijing, China participated in this cross-sectional investigation. Data on their perceived stress, psychological well-being, the impact of event, and reflective function during the COVID-19 pandemic were collected using self-report questionnaires. Different mediating models were tested. Results COVID-19-related stress symptoms and mentalization independently mediate the association between perceived stress and psychological well-being. These two mediators also compose a serial mediation model. In particular, higher perceived stress inhibits the psychological well-being of HCWs through increased severity of traumatic stress symptoms, which in turn is associated with hypomentalizing. Conclusion These findings shed light on the mechanisms underlying the relationship between perceived stress and psychological well-being in HCWs. We strongly recommend incorporating a mentalization framework with trauma-informed practice in prevention and intervention work with this population during this and future healthcare crisis.
Læs mere Tjek på PubMedTyler M. Balon, Yun Xia, Johnny McKeown, Jack Wang, Justin J. Abbott, Marilly Palettas, Alberto Uribe, Marco Echeverria Villalobos, John C. Coffman, Ling-Qun Hu
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Tyler M. Balon, Yun Xia, Johnny McKeown, Jack Wang, Justin J. Abbott, Marilly Palettas, Alberto Uribe, Marco Echeverria Villalobos, John C. Coffman, Ling-Qun Hu Shortening analgesic onset has been researched and it has been documented that prewarming epidural medications to body temperature (37°C) prior to administration increases medication efficacy. Our double-blind randomized controlled trial was designed to investigate if a lower degree of prewarming in providers’ pockets could achieve similar results without the need of a bedside incubator. A total of 136 parturients were randomized into either the pocket-warmed group or the room temperature group to receive 10 mL of 0.125% bupivacaine with 2 μg/mL fentanyl epidural bolus at either the 27.8 ±1.7°C or 22.1 ±1.0°C temperatures, respectively. Primary outcome, time to analgesic onset (verbal rating scale pain score ≤ 3) was recorded in 0-, 5-, 10-, 15-, 20-, 30-, and 60-minutes intervals. It was observed that the pocket-warming group (n = 64) and room temperature group (n = 72) had no significant difference of analgesic onset time (median 8 vs. 6.2 minutes; p = 0.322). The incidence of adverse events such as hypotension, fever (≥ 38°C), nausea, vomiting, and number of top-off epidural boluses, as well as patient satisfaction rates and mode of delivery, were not significantly different between the groups as well. Further research is warranted to confirm these findings and explore the impact of different temperatures on analgesic onset time as well as the logistical issues associated with their clinical implementations.
Læs mere Tjek på PubMedKirill Nazarov, Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Saleh Alrhmoun, Marina Volynets, Julia Shevchenko, Sergey Sennikov
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Kirill Nazarov, Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Saleh Alrhmoun, Marina Volynets, Julia Shevchenko, Sergey Sennikov Hemorrhage, a condition that accompanies most physical trauma cases, remains an important field of study, a field that has been extensively studied in the immunological context for myeloid and lymphoid cells, but not as much for erythroid cells. In this study, we studied the immunological response of murine erythroid cells to acute blood loss using flow cytometry, NanoString immune transcriptome profiling, and BioPlex cytokine secretome profiling. We observed that acute blood loss forces the differentiation of murine erythroid cells in both bone marrow and spleen and that there was an up-regulation of several immune response genes, in particular pathogen-associated molecular pattern sensing gene Clec5a in post-acute blood loss murine bone marrow erythroid cells. We believe that the up-regulation of the Clec5a gene in bone marrow erythroid cells could help bone marrow erythroid cells detect and eliminate pathogens with the help of reactive oxygen species and antimicrobial proteins calprotectin and cathelicidin, the genes of which (S100a8, S100a9, and Camp) dominate the expression in bone marrow erythroid cells of mice.
Læs mere Tjek på PubMedHexin Li, Negin Ashrafi, Chris Kang, Guanlan Zhao, Yubing Chen, Maryam Pishgar
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Hexin Li, Negin Ashrafi, Chris Kang, Guanlan Zhao, Yubing Chen, Maryam Pishgar Background Mechanical ventilation (MV) is vital for critically ill ICU patients but carries significant mortality risks. This study aims to develop a predictive model to estimate hospital mortality among MV patients, utilizing comprehensive health data to assist ICU physicians with early-stage alerts. Methods We developed a Machine Learning (ML) framework to predict hospital mortality in ICU patients receiving MV. Using the MIMIC-III database, we identified 25,202 eligible patients through ICD-9 codes. We employed backward elimination and the Lasso method, selecting 32 features based on clinical insights and literature. Data preprocessing included eliminating columns with over 90% missing data and using mean imputation for the remaining missing values. To address class imbalance, we used the Synthetic Minority Over-sampling Technique (SMOTE). We evaluated several ML models, including CatBoost, XGBoost, Decision Tree, Random Forest, Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Logistic Regression, using a 70/30 train-test split. The CatBoost model was chosen for its superior performance in terms of accuracy, precision, recall, F1-score, AUROC metrics, and calibration plots. Results The study involved a cohort of 25,202 patients on MV. The CatBoost model attained an AUROC of 0.862, an increase from an initial AUROC of 0.821, which was the best reported in the literature. It also demonstrated an accuracy of 0.789, an F1-score of 0.747, and better calibration, outperforming other models. These improvements are due to systematic feature selection and the robust gradient boosting architecture of CatBoost. Conclusion The preprocessing methodology significantly reduced the number of relevant features, simplifying computational processes, and identified critical features previously overlooked. Integrating these features and tuning the parameters, our model demonstrated strong generalization to unseen data. This highlights the potential of ML as a crucial tool in ICUs, enhancing resource allocation and providing more personalized interventions for MV patients.
Læs mere Tjek på PubMedKhalid Aljohani
PLoS One Infectious Diseases, 5.09.2024
Tilføjet 5.09.2024
by Khalid Aljohani In recent decades, unfavorable solubility of novel therapeutic agents is considered as an important challenge in pharmaceutical industry. Supercritical carbon dioxide (SCCO2) is known as a green, cost-effective, high-performance, and promising solvent to develop the low solubility of drugs with the aim of enhancing their therapeutic effects. The prominent objective of this study is to improve and modify disparate predictive models through artificial intelligence (AI) to estimate the optimized value of the Oxaprozin solubility in SCCO2 system. In this paper, three different models were selected to develop models on a solubility dataset. Pressure (bar) and temperature (K) are the two inputs for each vector, and each vector has one output (solubility). Selected models include NU-SVM, Linear-SVM, and Decision Tree (DT). Models were optimized through hyper-parameters and assessed applying standard metrics. Considering R-squared metric, NU-SVM, Linear-SVM, and DT have scores of 0.994, 0.854, and 0.950, respectively. Also, they have RMSE error rates of 3.0982E-05, 1.5024E-04, and 1.1680E-04, respectively. Based on the evaluations made, NU-SVM was considered as the most precise method, and optimal values can be summarized as (T = 336.05 K, P = 400.0 bar, solubility = 0.00127) employing this model. Fig 4
Læs mere Tjek på PubMedLinda M. HeffernanAnna-Lisa E. LawrenceHaley A. MarcotteAmit SharmaAria X. JenkinsDamilola IguweJennifer RoodScott W. HerkeMary X. O'RiordanBasel H. Abuaita1Department of Pathobiological Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge, Louisiana, USA2Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA3Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA4Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USAManuela Raffatellu
Infection and Immunity, 4.09.2024
Tilføjet 4.09.2024
Adi N. R. PoliIan TietjenNitesh K. NandwanaJoel CasselTroy E. MessickEmery T. RegisterFrederick KeeneyRajesh RajaiahAtul K. VermaKabita PandeyArpan AcharyaSiddappa N. ByrareddyLuis J. MontanerJoseph M. Salvino1Medicinal Chemistry, The Wistar Institute, Philadelphia, Pennsylvania, USA2HIV-1 Program in the Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA3The Wistar Cancer Center Molecular Screening, The Wistar Institute, Philadelphia, Pennsylvania, USA4The Wistar Institute, Philadelphia, Pennsylvania, USA5Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA6Molecular and Cellular Oncogenesis (MCO) Program, The Wistar Institute, Philadelphia, Pennsylvania, USAMiguel Angel Martinez
Antimicrobial Agents And Chemotherapy, 4.09.2024
Tilføjet 4.09.2024
Infection, 4.09.2024
Tilføjet 4.09.2024
Infection, 4.09.2024
Tilføjet 4.09.2024
Hiromu Tanaka, Takanori Asakura, Satoshi Okamori, Koji Furuuchi, Mitsuaki Yagi, Yuji Nakayama, Junko Kuramoto, Kazuma Yagi, Isano Hase, Hirofumi Kamata, Keiji Fujirawa, Akira Nakao, Yohei Masugi, Yasunori Sato, Yae Kanai, Ho Namkoong, Koichi Fukunaga, Taku Nakagawa, Kozo Morimoto, Masaki Fujita, Naoki Hasegawa
International Journal of Infectious Diseases, 4.09.2024
Tilføjet 4.09.2024
Nontuberculous mycobacterial (NTM) pulmonary disease (NTM-PD) is a chronic respiratory infection that has a negative effect on the quality of life. Its incidence is increasing worldwide, including in Japan [1]. Traditionally, NTM-PD is classified into two main phenotypes based on imaging findings: fibrocavitary (FC) and nodular/bronchiectatic (NB). The FC type, characterized by cavitary lesions in the upper lobes, is more prevalent among men with underlying lung disease, including previous pulmonary tuberculosis and chronic obstructive pulmonary disease [2].
Læs mere Tjek på PubMedLingyun Song, Yilin Zhang, Feng Sun, Yuanbo Lan, Jie Tong, Shijia Ge, Zhen Feng, Rong Li, Hongying Yu, Yang Li, Wenhong Zhang
International Journal of Infectious Diseases, 4.09.2024
Tilføjet 4.09.2024
Drug-resistant tuberculosis poses a significant public health challenge worldwide, threatening global tuberculosis (TB) control efforts. In 2022, an estimated 410,000 new cases of rifampicin-resistant tuberculosis (RR-TB) were reported, presenting considerable treatment difficulties [1]. Historically, the treatment for RR-TB has been lengthy and arduous, involving a higher pill burden and increased risk of adverse effects compared to treatments for drug-susceptible tuberculosis [2]. The last decade, however, has seen considerable progress in shortening treatment durations, which has simplified the management of RR-TB [3].
Læs mere Tjek på PubMedRhee, A., Granville Smith, I., Compte, R., Vehof, J., Nessa, A., Wadge, S., Freidin, M. B., Bennett, D. L., Williams, F. M. K.
BMJ Open, 4.09.2024
Tilføjet 4.09.2024
ObjectiveThe chronic pain syndromes (CPS) include syndromes such as chronic widespread pain (CWP), dry eye disease (DED) and irritable bowel syndrome (IBS). Highly prevalent and lacking pathognomonic biomarkers, the CPS are known to cluster in individuals in part due to their genetic overlap, but patient diagnosis can be difficult. The success of quantitative sensory testing (QST) and inflammatory biomarkers as phenotyping tools in conditions such as painful neuropathies warrant their investigation in CPS. We aimed to examine whether individual QST modalities and candidate inflammatory markers were associated with CWP, DED or IBS in a large, highly phenotyped population sample. DesignCross-sectional study. SettingCommunity-dwelling cohort. ParticipantsTwins from the TwinsUK cohort Primary and secondary outcome measuresWe compared 10 QST modalities, measured in participants with and without a CWP diagnosis between 2007 and 2012. We investigated whether inflammatory markers measured by Olink were associated with CWP, including interleukin-6 (IL-6), IL-8, IL-10, monocyte chemoattractant protein-1 and tumour necrosis factor. All analyses were repeated in DED and IBS with correction for multiple testing. ResultsIn N=3022 twins (95.8% women), no association was identified between individual QST modalities and CPS diagnoses (CWP, DED and IBS). Analyses of candidate inflammatory marker levels and CPS diagnoses in n=1368 twins also failed to meet statistical significance. ConclusionOur findings in a large population cohort suggest a lack of true association between singular QST modalities or candidate inflammatory markers and CPS.
Læs mere Tjek på PubMedAdam A. CapoferriAnn WiegandFeiyu HongJana L. JacobsJonathan SpindlerAndrew MusickMichael J. BaleWei ShaoMichele D. SobolewskiAnthony R. CilloBrian T. LukeChristine M. FennesseyRobert J. GorelickRebecca HohElias K. HalvasSteven G. DeeksJohn M. CoffinJohn W. MellorsMary F. KearneyaHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702bDepartment of Microbiology and Immunology, Georgetown University, Washington, DC 20007cDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213dLeidos Biomedical Research, Inc., Frederick National Laboratories for Cancer Research, Frederick, MD 21702eLaboratory of Epigenetics and Immunity, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065fDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261gAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702hDepartment of Medicine, University of California, San Francisco, CA 94143iDepartment of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111
Proceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMedJie HouYuqi LuQiqi ChenXinyi LiaoXinyue WuKaijian SangJason C. WhiteJorge L. Gardea-TorresdeyJiang XuJianying ZhangKun YangLizhong ZhuDaohui LinaZhejiang Provincial Key Laboratory of Organic Pollution Process and Control, Department of Environmental Science, Zhejiang University, Hangzhou 310058, ChinabZhejiang University-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou 311200, ChinacThe Connecticut Agricultural Experiment Station, New Haven, CT 06511dDepartment of Chemistry & Biochemistry, The University of Texas at El Paso, El Paso, TX 79968eNational Demonstration Center for Experimental Environment and Resources Education, College of Environmental and Resource Sciences, Zhejiang University, Hangzhou 310058, China
Proceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMedShenjia GaoRuling ShenJie LiYi JiangHao SunXinyi WuXiya LiChanghong MiaoMiao HeJun WangWankun ChenaDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinabShanghai Key Laboratory of Perioperative Stress and Protection, Shanghai 200032, ChinacShanghai Laboratory Animal Research Center, Shanghai 201203, ChinadInstitutes of Brain Science, State Key Laboratory of Medical Neurobiology and Ministry of Education (MOE) Frontiers Center for Brain Science, Shanghai 200032, ChinaeDepartment of Neurobiology, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinafDepartment of Integrative Medicine and Neurobiology, School of Basic Medical Science, Shanghai Key Laboratory of Acupuncture Mechanism and Acupoint Function, Fudan University, Shanghai 200032, ChinagDepartment of Anesthesiology, Shanghai Geriatric Medical Center, Shanghai 201104, ChinahDepartment of Anesthesiology, QingPu Branch of Zhongshan Hospital, Fudan University, Shanghai 201799, China
Proceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMedCara E. BrookCarly RozinsJennifer A. BohlVida AhyongSophana CheaLiz FahsbenderRekol HuySreyngim LayRithea LeangYimei LiChanthap LonSomnang ManMengheng OumGraham R. NorthrupFabiano OliveiraAndrea R. PachecoDaniel M. ParkerKatherine YoungMichael BootsCristina M. TatoJoseph L. DeRisiChristina YekJessica E. ManningaDepartment of Ecology and Evolution, University of Chicago, Chicago, IL 60637bDepartment of Science, Technology, and Society, York University, Toronto, ON M3J 1P3, CanadacLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20892dChan Zuckerberg Biohub, San Francisco, CA 94158eInternational Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, CambodiafChan Zuckerberg Initiative, Redwood City, CA 94063gNational Center for Parasitology, Entomology, and Malaria Control, Phnom Penh 120801, CambodiahCenter for Computational Biology, University of California, Berkeley, CA 94720iDepartment of Population Health and Disease Prevention, University of California, Irvine, CA 92697jDepartment of Epidemiology and Biostatistics, University of California, Irvine, CA 92697kDepartment of Biological Sciences, University of Texas, El Paso, TX 79968lDepartment of Integrative Biology, University of California, Berkeley, CA 94720
Proceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMedElze HesseAdela M. LujánSiobhan O’BrienArthur NewburyTerence McAvoyJesica Soria PascualFlorian BayerDavid J. HodgsonAngus BucklingaCentre for Ecology and Conservation & Environment and Sustainability Institute, Faculty of Environment, Science and Economy, University of Exeter, Cornwall TR10 9FE, United KingdombCentro de Investigación y Desarrollo en Inmunología y Enfermedades Infecciosas, Consejo Nacional de Investigaciones Científicas y Técnicas/Universidad Católica de Córdoba, Córdoba X5016DHK, ArgentinacFacultad de Ciencias de la Salud, Universidad Católica de Córdoba (UCC), Córdoba X5004ASK, ArgentinadCentre for Ecology and Conservation, Faculty of Environment, Science and Economy, University of Exeter, Cornwall TR10 9FE, United Kingdom
Proceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMedDustin R. GlasnerMatthew D. DaughertyaDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, CA 92093
Proceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMedProceedings of the National Academy of Sciences, 4.09.2024
Tilføjet 4.09.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 36, September 2024.
Læs mere Tjek på PubMed